Browsing Pharmacy Research by Author "Hamad, Anas"
Now showing items 1-4 of 4
-
Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital
Abushanab, Dina; Gulied, Amaal; Hamad, Anas; Abu-Tineh, Mohammad; Abdul Rouf, Palli V.; Al Hail, Moza; El-Kassem, Wessam; El Hajj, Maguy S.; Al-Badriyeh, Daoud... more authors ... less authors ( SAGE , 2023 , Article)Background: The economic benefit of the clinical pharmacist's role in ensuring the optimum use of medicines is potentially considerable, particularly when it comes to cancer management. We sought to evaluate the overall ... -
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation
Al-Ziftawi, Nour Hisham; Alam, Mohammed Fasihul; Elazzazy, Shereen; Shafie, Asrul Akmal; Hamad, Anas; Mohamed Ibrahim, Mohamed Izham... more authors ... less authors ( MDPI , 2022 , Article)Palbociclib and ribociclib are indicated in the first-line treatment of hormonal-receptor-positive HER-2 negative (HR+/HER-2 negative) advanced breast cancer. Despite their clinical benefit, they can increase healthcare ... -
Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis
Laila, Shafei; Bashir, Shaima; Chan, Esther W.; Abushanab, Dina; Hamad, Anas; Al-Badriyeh, Daoud... more authors ... less authors ( Elsevier , 2024 , Article)PurposeSelinexor is a first-in-class, oral selective-inhibitor-of-nuclear-export, granted accelerated approval by FDA (2019) for relapsed and refractory multiple myeloma (RRMM). We sought to quantitatively summarize the ... -
Predictors of community pharmacists’ readiness to manage the effective and safe use of oral anticancer medicines in a developing setting
Dahmani, Sara; Cerbito, Emelith Florendo; Hamad, Anas; Yusuff, Kazeem Babatunde ( SAGE Publications Ltd , 2022 , Article)Background: There is a paucity of studies about the readiness of community pharmacists to manage the safe and effective use of oral anticancer medicines (OAMs) in developing settings. Objectives: Using the readiness component ...